Evaxion Biotech AS (EVAX)
1.44
-0.24
(-14.29%)
USD |
NASDAQ |
Nov 15, 16:00
1.40
-0.04
(-2.78%)
After-Hours: 20:00
Evaxion Biotech Shares Outstanding: 5.578M for Sept. 5, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
September 05, 2024 | 5.578M |
August 15, 2024 | 5.576M |
August 06, 2024 | 5.576M |
July 31, 2024 | 5.575M |
July 17, 2024 | 5.411M |
June 30, 2024 | 5.411M |
June 07, 2024 | 5.411M |
April 25, 2024 | 5.411M |
April 18, 2024 | 5.411M |
March 15, 2024 | 5.215M |
February 05, 2024 | 4.812M |
January 29, 2024 | 4.054M |
January 26, 2024 | 4.054M |
January 11, 2024 | 3.791M |
January 04, 2024 | 3.790M |
December 31, 2023 | 3.790M |
December 21, 2023 | 3.790M |
November 01, 2023 | 2.792M |
October 13, 2023 | 2.787M |
September 30, 2023 | 2.781M |
September 25, 2023 | 2.766M |
September 13, 2023 | 2.765M |
August 11, 2023 | 2.765M |
July 11, 2023 | 2.764M |
June 30, 2023 | 2.764M |
Date | Value |
---|---|
June 09, 2023 | 2.687M |
March 31, 2023 | 2.644M |
March 22, 2023 | 2.642M |
February 24, 2023 | 2.642M |
February 02, 2023 | 2.528M |
December 31, 2022 | 2.414M |
December 27, 2022 | 2.414M |
September 23, 2022 | 2.398M |
June 30, 2022 | 2.383M |
June 07, 2022 | 2.326M |
May 19, 2022 | 2.326M |
May 15, 2022 | 2.326M |
April 12, 2022 | 2.320M |
March 31, 2022 | 2.320M |
December 31, 2021 | 2.320M |
November 09, 2021 | 2.314M |
September 30, 2021 | 1.920M |
June 30, 2021 | 1.920M |
June 23, 2021 | 1.920M |
May 26, 2021 | 1.920M |
March 31, 2021 | 1.920M |
February 05, 2021 | 1.920M |
January 25, 2021 | 1.895M |
December 31, 2020 | 1.620M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.620M
Minimum
Dec 31 2020
5.578M
Maximum
Sep 05 2024
3.242M
Average
2.764M
Median
Jun 30 2023
Shares Outstanding Benchmarks
Ascendis Pharma AS | 59.76M |
DBV Technologies SA | 96.20M |
Adaptimmune Therapeutics PLC | 255.88M |
Akari Therapeutics PLC | 11.95M |
Biodexa Pharmaceuticals PLC | 0.5808M |